Ursprung des Netzwerks ersten Grades von Mark Namchuk
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 74 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Mark Namchuk
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Sales & Marketing | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer | |
| YIELD10 BIOSCIENCE, INC. | Chemicals: Agricultural | General Counsel Director of Finance/CFO Investor Relations Contact | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Graduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Sales & Marketing Chief Executive Officer Director/Board Member | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
| The Reed Institute | College/University | Undergraduate Degree Undergraduate Degree | |
| Babson College | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Boston College | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Corporate Officer/Principal Doctorate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Boston Medical Center
 Boston Medical Center Hospital/Nursing ManagementHealth Services Boston Medical Center provides healthcare services. It provides a spectrum of pediatric and adult care services from primary to family medicine specialty care. The hospital is established in July 1996 and is headquartered in Boston, MA | Hospital/Nursing Management | Human Resources Officer Director/Board Member | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Vertex Pharmaceuticals (Europe) Ltd.
 Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | Medical Distributors | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Accelerated Cure Project for Multiple Sclerosis
 Accelerated Cure Project for Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services The Accelerated Cure Project for Multiple Sclerosis cures multiple sclerosis (MS) by determining the cause. It specializes in research, biobanking, collaboration, fundraising, nonprofit. The company was founded by Art Mellor in 2000 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| The Warren Alpert Medical School | College/University | Doctorate Degree Doctorate Degree | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| SOLID BIOSCIENCES INC. | Biotechnology | Chief Operating Officer Chairman Chief Executive Officer | |
| STOKE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Public Communications Contact | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Director/Board Member | |
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Biotechnology | Chief Operating Officer Director/Board Member Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 4 |
| Frankreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Health Services | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 339 |
| Corporate Officer/Principal | 218 |
| Independent Dir/Board Member | 87 |
| Chairman | 78 |
| Undergraduate Degree | 67 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jeffrey Leiden | 43 |
| Charlie Sanders | 38 |
| Bruce Sachs | 35 |
| Wayne Riley | 34 |
| Richard H. Aldrich | 31 |
| N. Coles | 30 |
| Freda Lewis-Hall | 29 |
| Vicki Sato | 28 |
| Stuart J. M. Collinson | 25 |
| Wei Li | 24 |
| Ian Smith | 24 |
| Nancy Wysenski | 20 |
| Eric Brandt | 20 |
| Pravin Ramsewak Chaturvedi | 19 |
| Thierry Hercend | 18 |
- Börse
- Insiders
- Mark Namchuk
- Unternehmensverbindungen